Ceapro IncTSXV:CZOView on OTCQX International
- LAST PRICE0.2500
- TODAY'S CHANGE (%)0.0100 (4.1667%)
- Bid / Lots0.2400/ 2,786
- Ask / Lots0.2600/ 40
- Open / Previous Close0.2450 / 0.2400
- Day Range
- 52 Week Range
- Volume62,000
Search Criteria
Filter search criteria using below inputs
Click on magnifying glass icon to search
| Company | Country | Symbol |
|---|
- TSX Comp
- TSX Venture
- DJIA
- S&P 500
- NASDAQ
| Time | Volume | CZO |
|---|---|---|
| 09:32 ET | 1000 | 0.245 |
| 11:08 ET | 46000 | 0.24 |
| 12:52 ET | 7500 | 0.25 |
| 12:54 ET | 7500 | 0.25 |
Mar 28, 2024
Ceapro Receives Final Court Approval for Merger with Aeterna Zentaris, from 7:55AM ET on Thursday Mar 28, 2024 by Dow Jones
7:55AM ET on Thursday Mar 28, 2024 by Dow JonesCeapro Receives Final Court Approval for Merger with Aeterna Zentaris, from 7:55AM ET on Thursday Mar 28, 2024 by Dow Jones
7:55AM ET on Thursday Mar 28, 2024 by Dow Jones*DJ Ceapro Receives Final Court Approval For Merger With Aeterna Zentaris AEZS, from 7:55AM ET on Thursday Mar 28, 2024 by Dow Jones
7:55AM ET on Thursday Mar 28, 2024 by Dow Jones
| Company sortable | Market Cap sortable | P/E Ratio (TTM) sortable | EPS Growth (5yr) sortable |
|---|---|---|---|
Ceapro Inc | 18.7M | -7.2x | --- |
Medicure Inc | 10.6M | -11.4x | --- |
Avicanna Inc | 31.3M | -3.4x | --- |
Numinus Wellness Inc | 25.3M | -0.7x | --- |
Immunoprecise Antibodies Ltd | 31.4M | -3.1x | --- |
Microbix Biosystems Inc | 46.0M | 12.2x | --- |
Company Information
Ceapro Inc. is a Canada-based biotechnology company. The Company is involved in the development of extraction technology and the application of this technology to the production of extracts and active ingredients from oats and other renewable plant resources. Its primary business activities relate to the development and commercialization of natural products for personal care, cosmetic, human, and animal health industries using technology, natural, renewable resources, and developing products, technologies, and delivery systems. The Company's products include a commercial line of natural active ingredients, including beta glucan, avenanthramides (colloidal oat extract), oat powder, oat oil, oat peptides, and lupin peptides, a commercial line of natural anti-aging skincare products, utilizing active ingredients, including beta glucan and avenanthramides and veterinary therapeutic products, including an oat shampoo, an ear cleanser, and a dermal complex/conditioner.
Contact Information
- Headquarters
- 7824 51 Ave NWEDMONTON, AB, Canada T6E 6W2
- Phone
- 780-421-4555
- Fax
- 780-421-1320
Executives
- Independent Chairman of the Board
- Ronald Miller
- Chief Executive Officer, Director
- Gilles Gagnon
- Chief Financial Officer
- Stacy Prefontaine
- Independent Director
- Genevieve Foster
- Independent Director
- Ulrich Kosciessa
Our Ratings feature offers company-specific research ratings from providers such as First Call, S&P and Argus.
Open a New Account, or Login if you're a client.
You have access to a comprehensive selection of independent research reports from providers such as TD Securities, S&P, INK, and Argus.
Open a New Account, or Login if you're a client.
Market Cap | $18.7M |
|---|---|
Revenue (TTM) | $11.3M |
Shares Outstanding | 78.3M |
Ceapro Inc does not pay a dividend. | |
Beta | 1.38 |
EPS | $-0.03 |
Book Value | $0.41 |
P/E Ratio | -7.2x |
Price/Sales (TTM) | 1.7 |
Price/Cash Flow (TTM) | --- |
Operating Margin | -34.49% |
Our Calendar feature allows you to view a wide selection of market and company events, including earnings, dividends, splits, rating changes, guidance, and more. Access past, current and future events in WebBroker.
Open a New Account, or Login if you're a client.
